factor V Lei·den -ˈlī-dᵊn 1 : a point mutation producing an abnormal version of factor V that is resistant to inactivation and causes prolonged clotting of blood 2 also factor V Leiden thrombophilia : a genetic disorder caused by factor V Leiden that is marked by an ...
(redirected fromFactor V Leiden mutation) Thesaurus Medical Legal Acronyms Encyclopedia mu·ta·tion (myo͞o-tā′shən) n. 1.The act or process of being altered or changed. 2.An alteration or change, as in nature, form, or quality. ...
Factor V Leiden 第五凝血因子；莱登第五因子 第五凝血因子 检验第五凝血因子(Factor V leiden)上的G1691A突变：造成容易产生血栓的体质(血栓病, thrombophilia)。北美洲有 5% 的人遗传有莱登第五因子 ( Factor V Leiden )﹐影响凝血功能。 年长﹑肥胖﹑抽烟﹐与及曾经出现过静脉栓塞症状的人士﹐再次...
factor-V Leidenfactor-V Leiden A common mutation of coagulation factor-V gene, which is found in 3 to 8% of Caucasians, and results in resistance to activated C protein and an increased risk in deep-vein and other thromboses. Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights...
Pabinger I, Ay C, Dunkler D, Thaler J, Reitter EM, Marosi C, et al. Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients--results from the vienna cancer and thrombosis study (CATS). J Thromb Haemost 2015;13:17-22....
and Caribbean StudiesinLeiden. wdl.org wdl.org 这本pustaha 书叙述的是对抗邪恶的保护方式,出自位于莱顿的KITLV/荷兰皇家东南亚和加勒比研究所的藏品。 wdl.org wdl.org Similar to material intensity the energy intensity cannot be used to quantify specific environmental pressures (e.g. ozone depletion) ra...
Factor V Leiden testing may be indicated in clinical scenarios where results can help guide clinical decisions for the patient and family members. These clinical scenarios include first VTE developed under 50 years of age, VTE at an unusual site (eg, cerebral veins), recurrent VTE, a strong fa...
Factor V Leiden mutation is a common genetic risk factor for venous thrombosis. It has been documented in up to 65% of patients with unexplained venous thromboembolism. This genetic mutation is now known to be the most common inherited cause of activated protein C (APC) resistance. Recently, ...
Aim. Lebanon exhibits one of the highest prevalences of factor V-Leiden (FVL) in the world (14.4%). The aim of this study is to evaluate the incidence of FVL mutation among Lebanese patients with lower extremity venous thrombosis. Material and Methods. From January 2003 to January 2011, 28...
Factor V Leiden mutation in association with idiopathic intracranial hypertension (letter) Backhouse O et al: Factor V Leiden mutation in association with idiopathic intracranial hypertension. Br J Ophtalmol. 1998 Jul;82(7):844O. Backhouse, ......